We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Energy Recovery
ERII
$362M
| $472K | ﹤0.01% |
+35,525
| New | +$490K |
|
1327
Darling Ingredients
DAR
$10.3B
| $470K | ﹤0.01% |
12,790
-5,490
| -30% | -$228K |
|
1328
Harley-Davidson
HOG
$2.79B
| $469K | ﹤0.01% |
13,997
-1,015
| -7% | -$36.9K |
|
1329
Ferguson
FERG
$41.5B
| $467K | ﹤0.01% |
2,411
-3,233
| -57% | -$678K |
|
1330
Amkor Technology
AMKR
$11.5B
| $465K | ﹤0.01% |
11,630
-15
| -0.1% | -$497 |
|
1331
Leslie's
LESL
$5M
| $464K | ﹤0.01% |
+5,542
| New | +$539K |
|
|
RYZ
1332
Ryerson Holding Corp
RYZ
$1.26B
| $462K | ﹤0.01% |
23,713
-33,533
| -59% | -$864K |
|
1333
Flowers Foods
FLO
$1.3B
| $462K | ﹤0.01% |
20,818
-3,486
| -14% | -$82.5K |
|
|
JHG
1334
DELISTED
Janus Henderson
JHG
| $456K | ﹤0.01% |
13,518
-6,608
| -33% | -$217K |
|
1335
SLM Corp
SLM
$4.75B
| $453K | ﹤0.01% |
21,775
-8,182
| -27% | -$172K |
|
1336
Federal Agricultural Mortgage
AGM
$2.39B
| $450K | ﹤0.01% |
2,489
+4
| +0.2% | +$722 |
|
1337
Avient
AVNT
$3.75B
| $447K | ﹤0.01% |
10,245
-534
| -5% | -$23.4K |
|
1338
Atlassian
TEAM
$48.2B
| $444K | ﹤0.01% |
+2,510
| New | +$449K |
|
1339
Home BancShares
HOMB
$5.95B
| $441K | ﹤0.01% |
18,404
-1,054
| -5% | -$25K |
|
1340
Belden
BDC
$4.4B
| $439K | ﹤0.01% |
4,685
-369
| -7% | -$33.5K |
|
1341
Starbucks
SBUX
$111B
| $438K | ﹤0.01% |
5,622
-63,190
| -92% | -$5.15M |
|
1342
Capri Holdings
CPRI
$1.67B
| $436K | ﹤0.01% |
13,172
+3,370
| +34% | +$122K |
|
1343
inTEST
INTT
$139M
| $436K | ﹤0.01% |
+44,091
| New | +$471K |
|
1344
NXP Semiconductors
NXPI
$55.2B
| $435K | ﹤0.01% |
1,617
+406
| +34% | +$105K |
|
|
WAY
1345
Waystar Holding Corp
WAY
$5.1B
| $430K | ﹤0.01% |
+20,000
| New | +$433K |
|
1346
Match Group
MTCH
$10B
| $430K | ﹤0.01% |
14,152
-4,795
| -25% | -$151K |
|
1347
ScottsMiracle-Gro
SMG
$3.19B
| $429K | ﹤0.01% |
6,594
+1,520
| +30% | +$104K |
|
1348
First Financial Bankshares
FFIN
$4.78B
| $429K | ﹤0.01% |
14,521
+5,127
| +55% | +$154K |
|
|
SRCL
1349
DELISTED
Stericycle Inc
SRCL
| $427K | ﹤0.01% |
7,347
-2,774
| -27% | -$142K |
|
1350
Bank OZK
OZK
$5.23B
| $426K | ﹤0.01% |
10,388
-4,658
| -31% | -$203K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.